INSM
NASDAQ
$107.02
Insmed Inc (INSM)
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $196.38 (+83.50%)
Market Cap
$24B
Revenue 5Y CAGR
+37.33%
FCF 5Y CAGR
+25.64%
Free Cash Flow Yield
-3.88%
Price Chart
Valuation
Market Cap$24B
Forward P/E16.37
PEG1.09
P/S28.42
P/B33.77
Profitability
Total Revenue (TTM)$820M
Gross Profit (TTM)$670M
EBITDA-$1.14B
Profit Margin-53.5%
Operating Margin-50.1%
EPS-$5.55
Financial Health
Debt-to-Equity76.9%
Free Cash Flow Yield-3.88%
Growth & Risk
EPS 5Y CAGR+12.24%
Revenue 5Y CAGR+37.33%
FCF 5Y CAGR+25.64%
Beta (5Y)0.77
Sharpe Ratio0.25